Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy

L Cabel, C Proudhon, E Romano, N Girard… - Nature reviews Clinical …, 2018 - nature.com
Considerable interest surrounds the use of immune-checkpoint inhibitors in patients with
solid tumours following the demonstration of the impressive clinical efficacy of anti …
被引用次数：185 相关文章

[引用][C] Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy

L Cabel, C Proudhon, E Romano, N Girard… - Nature Reviews …, 2018 - cir.nii.ac.jp
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy.

L Cabel, C Proudhon, E Romano, N Girard… - Nature reviews …, 2018 - europepmc.org
Considerable interest surrounds the use of immune-checkpoint inhibitors in patients with
solid tumours following the demonstration of the impressive clinical efficacy of anti …

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy

L Cabel, C Proudhon, E Romano… - Nature reviews …, 2018 - pubmed.ncbi.nlm.nih.gov
Considerable interest surrounds the use of immune-checkpoint inhibitors in patients with
solid tumours following the demonstration of the impressive clinical efficacy of anti …